MK-8527 PK/PD Threshold and Phase 2 Dose
Selection for Monthly Oral HIV-1 Preexposure Prophylaxis
32nd CROI 2025 SF March 9-12
Yash Kapoor*; Barbara Evans; Russ P. Carstens; Tracy L. Diamond; Anjana Grandhi; Gillian Gillespie; Peggy Hwang; Ryan Vargo; Randolph P. Matthews; Jesse C. Nussbaum; Rebeca M. Plank
Merck & Co., Inc., Rahway, NJ, USA
*Presenting author.
